← Evidence map

ArticlePharmaceuticals (Basel, Switzerland)2012

Concerns regarding the use of dabigatran for stroke prevention in atrial fibrillation.

Claudia Stöllberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24288086